glp-1 cardiovascular outcomes 2025 news GLP-1s Could Improve Heart Health - PAD Treatment Centers What Ozempic and other GLP-1

An additional 4mg yielded only 1.4 percentage points of additional weight loss, while side effects increased notably

Moreover, existing data indicate that single-target GLP-1RAs such as SEMA and liraglutide show promising capabilities for fibrosis improvement, and the initial success of the dual agonist tirzepatide suggests potential benefits of dose titration therapy in the monotherapy management of MASLD

Scientific Reference 2: Wilding et al., New England Journal of Medicine (2021) 2

Patients should reach out if they experience persistent nausea, vomiting, or diarrhea that prevents adequate nutrition or hydration (which may lead to dehydration and kidney problems)